ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Todd M. Grehl
Edward J. Hurley
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grehl, T. M.
Right arrow Articles by Hurley, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grehl, T. M.
Right arrow Articles by Hurley, E. J.

Ann Thorac Surg 1980;30:173-176
© 1980 The Society of Thoracic Surgeons

Articles

Heterograft Cardiac Valve Prostheses: A Five-Year Follow-up

Todd M. Grehl, M.D.*, Jerome G. Naifeh, M.D., John Broda, M.D., Amrit Dajee, M.D., Edward J. Hurley, M.D.

From the University of California Davis Medical Center, Sacramento, Sacramento, CA

Accepted for publication January 4, 1980.

* Address reprint requests to Dr. Grehl, Section of Thoracic Surgery, 4301 X Street, Room 213, Sacramento, CA 95817

The major advance in the management of valvular heart disease over the past twenty years has been due to prosthetic valve operation. The bioprostheses have good hemodynamic function and a low rate of thromboembolism although the long-term durability is unknown. In this series of 25 patients with 27 valves implanted over five years, there was an 8% early mortality and a 12% late mortality. There have been no thromboembolic episodes. Primary valvular dysfunction requiring operation occurred in 7.4% (2 out of 27). All surviving patients are in New York Heart Association Functional Class I or II.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
L. H. Edmunds Jr.
Thrombotic and Bleeding Complications of Prosthetic Heart Valves
Ann. Thorac. Surg., October 1, 1987; 44(4): 430 - 445.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. E. David, W. I. C. Ho, and G. T. Christakis
Thromboembolism in Patients with Aortic Porcine Bioprostheses
Ann. Thorac. Surg., September 1, 1985; 40(3): 229 - 233.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. Nunez, M. G. Aguado, D. Celemin, A. Iglesias, and J. L. Larrea
Aspirin or Coumadin as the Drug of Choice for Valve Replacement with Porcine Bioprosthesis
Ann. Thorac. Surg., April 1, 1982; 33(4): 354 - 358.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1980 by The Society of Thoracic Surgeons.